2-propanol has been researched along with quinoxalines in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 6 (54.55) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crosson, CE; DeVries, GW; Heath, AR; Potter, DE | 1 |
Crosson, CE; Heath, AR; Ogidigben, MJ; Potter, DE | 1 |
Ohia, SE; Opere, CA | 1 |
Ang, RT; Chen, TC; Fan, JT; Grosskreutz, CL; Pasquale, LR | 1 |
Acheampong, AA; Burke, J; John, B; Shackleton, M; Tang-Liu, D; Wheeler, L | 1 |
Kasahara, N | 1 |
Kankuri, E; Kotikoski, H; Vapaatalo, H | 1 |
Iveković, R; Korsić, J; Mandić, Z; Masnec-Paskvalin, S; Novak-Laus, K; Zorić-Geber, M | 1 |
Chappa, AK; Jiang, S; Proksch, JW | 1 |
Arriola-Villalobos, P; Díaz-Valle, D; Garcia-Gil-de-Bernabé, J; Iglesias-Lodares, I | 1 |
Chen, Y; Kardon, RH | 1 |
2 trial(s) available for 2-propanol and quinoxalines
Article | Year |
---|---|
Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery.
Topics: Adrenergic alpha-Agonists; Aged; Anterior Eye Segment; Blood Pressure; Brimonidine Tartrate; Clonidine; Double-Blind Method; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Iris; Laser Therapy; Male; Ocular Hypertension; Ophthalmic Solutions; Postoperative Complications; Quinoxalines; Safety; Trabeculectomy | 2001 |
[Use of antiglaucoma therapy to reduce acute intraocular pressure rise following neodymium: YAG laser iridotomy in angle-closure glaucoma patients].
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Female; Glaucoma, Angle-Closure; Humans; Iris; Laser Therapy; Latanoprost; Male; Middle Aged; Miotics; Ocular Hypertension; Pilocarpine; Postoperative Complications; Prostaglandins F, Synthetic; Quinoxalines | 2006 |
9 other study(ies) available for 2-propanol and quinoxalines
Article | Year |
---|---|
Pharmacological evidence for heterogeneity of ocular alpha 2 adrenoceptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Benzazepines; Brimonidine Tartrate; Cats; Ciliary Body; Cyclic AMP; Dose-Response Relationship, Drug; Iris; Nictitating Membrane; Quinoxalines; Rabbits; Receptors, Adrenergic, alpha; Sympathetic Nervous System; Yohimbine | 1992 |
Functional evidence for heterogeneity of ocular alpha 2-adrenoceptors.
Topics: Anesthesia; Animals; Brimonidine Tartrate; Cats; Ciliary Body; Cyclic AMP; Dose-Response Relationship, Drug; Eye; Imidazoles; In Vitro Techniques; Iris; Isoproterenol; Medetomidine; Quinoxalines; Rabbits; Receptors, Adrenergic, alpha; Vasoactive Intestinal Peptide | 1990 |
Prejunctional alpha2-adrenoceptors and peroxide-induced potentiation of norepinephrine release from the bovine iris.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic Fibers; Animals; Brimonidine Tartrate; Cattle; Clonidine; Culture Techniques; Hydrogen Peroxide; Iris; Neuroeffector Junction; Norepinephrine; Oxymetazoline; Perfusion; Quinoxalines; Reactive Oxygen Species; Receptors, Adrenergic, alpha-2; Synaptic Transmission; Tritium; Yohimbine | 1998 |
Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes.
Topics: Administration, Topical; Animals; Brimonidine Tartrate; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Administration Schedule; Eye; Injections, Intraperitoneal; Iris; Macaca fascicularis; Metabolic Clearance Rate; Quinoxalines; Rabbits; Rats; Tissue Distribution; Vitreous Body | 2002 |
Brimonidine 0.2% to prevent post laser IOP elevation.
Topics: Antihypertensive Agents; Brimonidine Tartrate; Glaucoma; Humans; Intraocular Pressure; Iris; Laser Therapy; Ocular Hypertension; Postoperative Complications; Quinoxalines; Trabeculectomy | 2002 |
Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure.
Topics: Animals; Captopril; Ciliary Body; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanylate Cyclase; Intraocular Pressure; Iris; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitrites; Nitro Compounds; Nitrogen Oxides; Oxadiazoles; Penicillamine; Phosphodiesterase Inhibitors; Purinones; Quinoxalines; Rabbits; S-Nitrosothiols; Spermine; Swine; Time Factors | 2003 |
A rapid and sensitive LC/MS/MS assay for the quantitation of brimonidine in ocular fluids and tissues.
Topics: Adrenergic alpha-Agonists; Animals; Aqueous Humor; Brimonidine Tartrate; Chromatography, Liquid; Ciliary Body; Drug Stability; Eye; Iris; Linear Models; Quinoxalines; Rabbits; Reference Standards; Reproducibility of Results; Retina; Sensitivity and Specificity; Tandem Mass Spectrometry; Vitreous Body | 2009 |
[Pupillary block acute glaucoma due to acrylic intraocular lens posterior dislocation after Nd:YAG capsulotomy].
Topics: Acute Disease; Aged; Brimonidine Tartrate; Combined Modality Therapy; Dipyrone; Drug Therapy, Combination; Emergencies; Female; Furosemide; Glaucoma; Hernia; Humans; Iris; Laser Therapy; Lasers, Solid-State; Lens Capsule, Crystalline; Lens Subluxation; Lenses, Intraocular; Mannitol; Metoclopramide; Postoperative Complications; Pseudophakia; Pupil Disorders; Quinoxalines; Timolol; Vitrectomy; Vitreous Body | 2011 |
Studying the effect of iris mechanics on the pupillary light reflex using brimonidine-induced anisocoria.
Topics: Adult; Anisocoria; Brimonidine Tartrate; Female; Humans; Iris; Light; Male; Ophthalmic Solutions; Quinoxalines; Reflex, Pupillary; Sympatholytics | 2013 |